Dr. Nadine Shehata
Medical Officer, Canadian Blood Services
Associate Professor, Mount Sinai Hospital
1. Describe the mechanisms, manifestation, and investigation for hemolytic disease of the fetus and newborn.
2. Discuss options for prevention of hemolytic disease of the fetus and newborn.
1. Hemolytic Disease of the Fetus and Newborn: Modern Practice and Future Investigations. Hendrickson JE, Delaney M. Transfus Med Rev. 2016 Oct;30(4):159-64. doi: 10.1016/j.tmrv.2016.05.008. Epub 2016 May 26. Review. PMID: 27397673
2. Haemolytic disease of the fetus and newborn. de Haas M, Thurik FF, Koelewijn JM, van der Schoot CE. Vox Sang. 2015 Aug;109(2):99-113. doi: 10.1111/vox.12265. Epub 2015 Apr 20. Review. PMID: 25899660
Note: The session is a self-approved group learning activity (Section 1) as defined by the Maintenance of Certification program of The Royal College of Physicians and Surgeons of Canada.
To register for the LearnTransfusion series, send an email to learn.transfusion@blood.ca with “Weekly Transfusion Medicine Seminars” in the subject line. Include your name and complete e-mail address in the body of the e-mail, and confirm that you would like to register for the LearnTransfusion series. You will then receive weekly email notifications of upcoming series events with details on how to join the webinars (e.g., call-in number and a link to register for the webinar).
The LearnTransfusion series is the seminar component of the Areas of Focused Competency (AFC)-Diploma Program in Transfusion Medicine. The series, organized by Canadian Blood Services is also open to all practitioners in the field of Transfusion Medicine. Through a series of regular webinars, trainees and practitioners are exposed to various scientific, technical and clinical aspects of transfusion medicine.